Monte Rosa Therapeutics, Inc. (GLUE) NASDAQ

15.31

-0.37(-2.36%)

Updated at January 02 04:00PM

Currency In USD

Valuation

Market Cap512.94M
Enterprise Value331.4M
P/E Ratio60.23
PEG Ratio-5.27
Price/Sales Ratio5.49
Price/Book Ratio5.13
Enterprise/Revenue4.57
Enterprise/EBITDA42.38

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.12
Operating Margin0.05

Management Effectiveness

Return On Assets0.05
Return On Equity0.08

Income Statement

Revenue75.62M
Revenue/Share2.2
Gross Profit67.5M
EBITDA-72.99M
Net Income-72.7M
Diluted EPS-0.98

Balance Sheet

Total Cash391.26M
Total Cash/Share4.75
Total Debt40.17M
Total Debt/Equity0.16
Current Ratio6.54
Book Value Per Share2.98

Price History

52-Week Change122.21
52-Week High19.17
52-Week Low3.5
Moving Average 50 Days14.83
Moving Average 200 Days7.72

Statistics

Average Volume1.11M
Shares Outstanding65.12M
% Held by Institutions73.04

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A